Ascension Saint Francis - Reiman Cancer Center

Summary

Ascension Saint Francis - Reiman Cancer Center is a medical facility located in Franklin, Wisconsin. This center is recognized for care of Breast cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Ascension Saint Francis - Reiman Cancer Center is involved with conducting 50 clinical trials across 152 conditions. There are 5 research doctors associated with this hospital, such as Jonathan S. Treisman, Francis J. Cuevas, Shannon Offerman, and Ranveer Nand.

Top PIs

Clinical Trials running at Ascension Saint Francis - Reiman Cancer Center

Lung Cancer

Breast Cancer

Breast cancer

Non-Small Cell Lung Cancer

Colorectal Cancer

Cancer

Multiple Myeloma

Colon Cancer

Pancreatic Cancer

Melanoma

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Cancer Cachexia

for Colorectal, Lung, and Pancreatic Cancer

This study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic cancer that cannot be removed by surgery (unresectable) or is stage IV. Patients with these cancer types are at risk for developing cancer cachexia (CC), which is defined as weight loss, muscle loss, and fat loss due to cancer. CC has been associated with reduced physical performance, impaired quality of life, and poorer survival. Many studies that have evaluated treatments for cancer-related weight and muscle loss have aimed to treat all patients with weight loss exactly the same and, unfortunately, have not been successful. Like different cancer types, weight and muscle loss related to cancer may have different causes in different individuals and the best treatment strategy for this condition may not be a one-size-fits-all approach. Information gathered from this study may help researchers develop new diagnostic criteria for CC and design better treatments and clinical trials for cancer-related weight and muscle loss in the future to improve the quality of life in patients with advanced colorectal, lung, or pancreatic cancer.

Recruiting

1 award

N/A

7 criteria

Cannabis Use

for Breast Cancer

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

Recruiting

1 award

N/A

10 criteria